Literature DB >> 12713611

Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability.

A F Macedo1, F B Marques, C F Ribeiro, F Teixeira.   

Abstract

OBJECTIVES: To evaluate agreement between causality assessments of reported adverse drug reactions (ADRs) obtained from decisional algorithms, with those obtained from an expert panel using the WHO global introspection method (GI), according to different levels of imputability and to evaluate the influence of confounding variables.
METHOD: Two hundred reports were included in this study. An independent researcher used decisional algorithms, while an expert panel assessed the same ADR reports using the GI, both aimed at evaluating causality. Reports were divided according to the presence, absence or lack of information on confounding variables.
RESULTS: The rates of concordance between assessments made using the algorithms and GI according to levels of imputability were: 45% for 'certain', 61% for 'probable', 46% for 'possible' and 17% for drug unrelated terms. When confounding variables were taken into account, the rates of concordance for the 'absence of information', 'lack of information' and 'presence of confounding variables' in the 'certain' group were 49, 69 and 7%, respectively. The corresponding values for the 'probable' group were 80, 68 and 24% and 30, 51 and 51%, respectively for the 'possible' group.
CONCLUSION: Full agreement with global introspection was not found for any level of causality assessment. Confounding variables were found to be associated with low levels of agreement between decision algorithms and the GI method compromising the algorithms' sensitivity and specificity.

Mesh:

Year:  2003        PMID: 12713611     DOI: 10.1046/j.1365-2710.2003.00475.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  24 in total

1.  Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.

Authors:  Hélène Théophile; Yannick Arimone; Ghada Miremont-Salamé; Nicholas Moore; Annie Fourrier-Réglat; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.

Authors:  Paulo Roque Obreli-Neto; Alessandro Nobili; André de Oliveira Baldoni; Camilo Molino Guidoni; Divaldo Pereira de Lyra Júnior; Diogo Pilger; Juliano Duzanski; Mauro Tettamanti; Joice Mara Cruciol-Souza; Walderez Penteado Gaeti; Roberto Kenji Nakamura Cuman
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

3.  Agreement of expert judgment in causality assessment of adverse drug reactions.

Authors:  Yannick Arimone; Bernard Bégaud; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Nicholas Moore; Mathieu Molimard; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2005-04-13       Impact factor: 2.953

4.  Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?

Authors:  Ana F Macedo; Francisco B Marques; Carlos F Ribeiro
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.

Authors:  Yannick Arimone; Ghada Miremont-Salamé; Françoise Haramburu; Mathieu Molimard; Nicholas Moore; Annie Fourrier-Réglat; Bernard Bégaud
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

7.  Comparison of different methods for causality assessment of adverse drug reactions.

Authors:  Sapan Kumar Behera; Saibal Das; Alphienes Stanley Xavier; Srinivas Velupula; Selvarajan Sandhiya
Journal:  Int J Clin Pharm       Date:  2018-07-26

Review 8.  Does orlistat cause acute kidney injury?

Authors:  Michael M Beyea; Amit X Garg; Matthew A Weir
Journal:  Ther Adv Drug Saf       Date:  2012-04

9.  Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT).

Authors:  Sinem Ezgi Gulmez; Dominique Larrey; Georges-Philippe Pageaux; Séverine Lignot-Maleyran; Corinne de Vries; Miriam Sturkenboom; Susana Perez-Gutthann; Jacques Bénichou; Franco Bissoli; Yves Horsmans; Jacques Bernuau; Bruno Stricker; Douglas Thorburn; Patrick Blin; Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2012-08-10       Impact factor: 2.953

Review 10.  Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Alexander Schwarzenboeck; Johannes Schulze; Axel Eickhoff
Journal:  World J Hepatol       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.